Valuation: Yuhan Corporation

Market Cap 5,923B 4.42B 3.81B 3.6B 3.27B 6.13B 422B 6.16B 42.81B 16.46B 215B 16.59B 16.23B 679B P/E 2026 *
39.8x
P/E 2027 * 29.9x
Enterprise Value 5.84B 4.36M 3.76M 3.56M 3.22M 6.05M 416M 6.08M 42.24M 16.24M 212M 16.37M 16.01M 669M EV / Sales 2026 *
2.5x
EV / Sales 2027 * 2.29x
Free-Float
61.43%
Yield 2026 *
0.72%
Yield 2027 * 0.72%
1 day+0.63%
1 week-2.46%
Current month-5.14%
1 month-3.76%
3 months+2.85%
6 months-20.04%
Current year-29.36%
1 week 77,700
Extreme 77700
81,400
1 month 77,500
Extreme 77500
87,100
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
129,200
3 years 52,285.71
Extreme 52285.714285
166,900
5 years 47,571.43
Extreme 47571.428571
166,900
10 years 24,550.49
Extreme 24550.486545
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap. Importance
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%-2.46%-33.67%+12.81% 4.42B
-0.54%-4.26%+73.81%+33.50% 355B
+1.48%-1.11%+25.21%-18.93% 66.33B
+0.19%-2.71%+39.40%+161.27% 12.17B
+1.55%-6.88%-7.27%-17.48% 7.47B
-4.80%-8.31%-28.47%-8.74% 4.64B
-1.24%-6.98%-35.59%-10.53% 2.86B
-0.12%-4.34%-8.40%+38.66% 2.42B
-1.84%-5.00%-28.40%-26.72% 1.9B
-2.01%-2.36%-25.52%-16.52% 1.66B
Average -0.66%-4.36%-2.89%+14.73% 45.9B
Weighted average by Cap. -0.23%-4.15%+60.59%+27.18%

Financials

2026 *2027 *
Net sales 2,337B 1.74B 1.5B 1.42B 1.29B 2.42B 167B 2.43B 16.89B 6.5B 84.74B 6.55B 6.4B 268B 2,540B 1.89B 1.63B 1.55B 1.4B 2.63B 181B 2.64B 18.36B 7.06B 92.1B 7.12B 6.96B 291B
Net income 154B 115M 98.7M 93.46M 84.71M 159M 10.94B 160M 1.11B 427M 5.57B 430M 421M 17.59B 198B 148M 127M 120M 109M 205M 14.1B 206M 1.43B 550M 7.17B 554M 542M 22.66B
Net Debt -80.13B -59.78M -51.51M -48.77M -44.2M -82.93M -5.71B -83.35M -579M -223M -2.91B -225M -220M -9.18B -112B -83.19M -71.67M -67.87M -61.51M -115M -7.95B -116M -806M -310M -4.04B -312M -306M -12.78B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,082
Date Price Change Volume
26-09-11 ₩79,400.00 +0.63% 137,725
26-09-10 ₩78,900.00 -1.38% 409,069
26-09-09 ₩80,000.00 +1.14% 141,783
26-09-08 ₩79,100.00 -1.98% 163,702
26-09-07 ₩80,700.00 -0.86% 178,343
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
79,400.00KRW
Average target price
117,176.47KRW
Spread / Average Target
+47.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!